Experience with the balneological treatment of rheumatoid arthritis at a Republic hospital
Zaĭtseva, V.I.; Bersudskaia, S.L.; Gudilina, V.G.; Petrova, V.I.; Khakimdzhanov, A.K.
Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 51-53
1979
ISSN/ISBN: 0042-8787 PMID: 154770 Document Number: 151272
Document emailed within 1 workday
Related Documents
Taletene, I.P.; Gaigalene, B.A. 1984: Effect of combined chrisanol and balneological treatment on the clinical indicators and permeability of the synovian membrane in patients with rheumatoid arthritis Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2: 28-31Trnavský, K.; Bosmanský, K.; Zbojanová, M. 1983: Experience in the treatment of rheumatoid arthritis with piroxicam (Feldene) Casopis Lekaru Ceskych 122(1): 22-24
Hanova, P.; Pavelka, K.; Dostal, C.; Holcatova, I.; Pikhart, H. 2006: Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003 Clinical and Experimental Rheumatology 24(5): 499-507
Bisiarina, V.P.; Savitskaia, V.I.; Verimeevich, L.I.; Kachaeva, I.M.; Demchenko, V.I. 1982: Experience with using laser rays in the combined treatment of rheumatoid arthritis in children Pediatriia 3: 57-58
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Revaz, S.; Dudler, J. 2008: Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis Revue Medicale Suisse 4(149): 712; 714 716-717
Langdon, C.G.; Moran, D.G.; Jamieson, V.; Spence, S.; Hill, S.A. 1990: A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice Journal of International Medical Research 18(6): 489-496
Hledík, F. 1976: Automatic system for the management of balneological care and balneological production Casopis Lekaru Ceskych 115(49-50): 1547
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Dougados, M.; Torley, H. 1993: Efficacy of cyclosporin a in rheumatoid arthritis: worldwide experience British Journal of Rheumatology 32(Suppl 1): 57-59
Perales, J.; Junemann, C.; Berríos de la Luz, R.; Olivares, O. 1970: Experience with immunosuppressors in rheumatoid arthritis (a preliminary report) Revista Medica de Chile 98(1): 15-19
Lorber, A. 1981: Experience and rationale of monitoring plasma levels of gold in rheumatoid arthritis Agents and Actions. Supplements 8: 539-573